Does Medicaid Cover TRT? What Your State Requires in 2026

Does Medicaid cover TRT? Yes, it can cover testosterone replacement therapy for diagnosed hypogonadism. The 14 state and plan examples below show testosterone listings or approval rules. Coverage depends on your diagnosis, exact product, prescriber, and plan; your copay is plan-specific. Check Medicaid before paying a cash clinic.

By TRT Provider Guide · Last verified: October 2026 (sources checked October 22, 2026) · Editorial research from public documents; not clinically reviewed · Educational information, not medical advice

Last updated: October 22, 2026.

Who this guide is for: U.S. adults on Medicaid who are being checked or treated for male hypogonadism (low testosterone caused by a problem in the testicles or the brain's hormone signals). If you have Medicare too, if testosterone is prescribed for gender-affirming care, or if you're under 18, the rules are different — jump to special situations.

That's the short answer. Here's the part almost nobody tells you: a request can fail for reasons that have nothing to do with your testosterone level. Sometimes it's the wrong diagnosis on the form. Sometimes it's the wrong product. And sometimes it's the wrong prescriber. We'll show you all three — and how to avoid them.

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to explore online TRT programs and the questions to ask before you pay. It is educational and does not check Medicaid coverage. If you already know you want to use your Medicaid, start with the coverage checklist below.

---

Does Medicaid cover TRT?

Yes. Medicaid can pay for testosterone replacement therapy for diagnosed hypogonadism. Approval also depends on your program's clinical and product criteria, the records submitted, and the prescriber's enrollment.

Here's why it can be covered. All states currently provide an outpatient prescription-drug benefit. Federal rebate-program rules generally require coverage of participating manufacturers' covered outpatient drugs, subject to allowed exclusions and approval rules. States use a preferred drug list (the plan's list of favored medicines) and prior authorization (approval your prescriber must get before the plan pays).

Testosterone is not listed as a drug class states may exclude outright under this federal provision. But there's a catch. The prescribed use and product still have to meet coverage rules, and the law restricts payment for drugs used to treat sexual or erectile dysfunction.

That's why the diagnosis on the request matters so much.

We read a public Medicaid hearing decision to see why a real request failed. In a 2025 Massachusetts hearing, a denial of compounded testosterone cream was upheld because the request documented only hypoactive sexual disorder, an excluded use, and did not document trials of less costly available alternatives.

That case shows why the diagnosis and supporting records matter — what was asked for and why. Your clinician decides what diagnosis is medically accurate — never ask anyone to change your records to fit a rule. But it's fair to ask, "What diagnosis and records are going on this request?"

---

What do state Medicaid programs actually require for testosterone?

Each state — and sometimes each Medicaid health plan inside a state — sets its own testosterone rules. The examples below show why the exact product and benefit matter: a preferred listing, a required trial of another drug, and prior authorization are different rules.

We pulled official drug lists, prior-authorization forms, and Medicaid health plan policies for 14 state or plan examples and lined them up on the same columns. Every row comes from the program's own document. Some currently posted criteria carry older revision dates; those dates are shown.

Medicaid Testosterone Rulebook: 14 state and plan examples, side by side (documents checked October 22, 2026)

This is a set of examples, not a 50-state coverage decision. Preferred does not mean a required first treatment or automatic approval. A dash means the listed source does not establish a numeric lab rule; it does not mean no testing is needed. Confirm the exact product and benefit with your plan.

What the table shows (our read of it):

1. There is no single injection-first rule. Several programs prefer both injections and gels. Florida lists Jatenzo as preferred, and Pennsylvania lists Testopel pellets as preferred — with authorization still required.
2. "Preferred" doesn't mean "automatic." Ohio, Oklahoma and Washington all attach prior authorization to preferred testosterone.
3. Brand vs. generic flips by state. New York prefers the generic gel pump. North Carolina prefers the brand and the generic. "Medicaid always prefers generics" isn't a safe rule.
4. Two morning tests appear in several clinical policies. Some forms use 300 ng/dL. Others use the lab's own normal range. Payer rules and medical diagnosis are separate questions.
5. Some plans still say no to "age-related" low testosterone. More on that below — it's a rule worth knowing about.

Your state isn't listed? Search "[your state] Medicaid preferred drug list androgens." Look for a class called "Androgens" or "Androgenic Agents." Or skip the hunt and call member services with the checklist below.

→ Know what your state favors? Use the coverage checklist to confirm your exact plan before anyone writes a prescription.

---

Which testosterone does Medicaid pay for first?

There is no single first product across Medicaid. Several programs prefer generic injections and selected gels; some also prefer an oral product or pellets. Check your exact product, because preferred status, prior authorization, and a required trial of another medicine are separate rules.

Injections

Generic testosterone cypionate and testosterone enanthate appear as preferred in several programs above. They can still need prior authorization. Brand Depo-Testosterone is preferred in some states and not others. For self-pay prices, see our testosterone cypionate cost guide.

Gels

Preferences vary. Arizona, Florida, Iowa and Oregon favor certain gels. New York and North Carolina split on brand vs. generic pumps. The exact product, strength, and package can change the answer — ask the pharmacy to check the exact one. Our testosterone gel cost guide covers self-pay pricing.

Some posted policies still name Androderm patches, but FDA's database lists them as discontinued. An old formulary entry does not prove a product is available.

Newer brands: Xyosted, Azmiro, Natesto, Jatenzo, Tlando, Kyzatrex

Several of these brands appear as non-preferred in the examples above, but there are exceptions. Florida lists Jatenzo as preferred while still requiring a failed injection trial in the past year. Preferred does not always mean no extra steps.

Pellets (Testopel) and Aveed

These are given by a clinician. That can mean a medical benefit claim instead of a pharmacy claim. Texas introduced prior authorization for specified clinician-administered hormone products in March 2024; its October 2026 handbook lists the current covered procedure codes that need PA. Pennsylvania lists Testopel as preferred with PA — pellets are not always non-preferred.

Compounded creams and other custom blends

Compounded means a pharmacy made a preparation for a patient's needs. Compounded drugs are not FDA-approved, and they are not the same thing as an FDA-approved generic. Coverage depends on the program and medical-necessity evidence. California's cited 2014 managed-care policy directs plans to use available FDA-approved products unless a compounded drug is medically necessary; that letter alone does not establish today's Medi-Cal Rx pharmacy rule. The Massachusetts hearing above also required documentation about less costly alternatives.

---

What must your doctor send for prior authorization?

Your doctor must send the records your plan requires: the diagnosis, symptoms, test results, and any product-trial or exception evidence. Several policies ask for two low morning tests; some also ask for LH and FSH results. First approvals can be shorter than a year.

Medical diagnosis and insurance paperwork aren't the same thing

Your clinician decides whether you have low testosterone. Medicaid decides whether it will pay. Those are two different questions.

The American Urological Association says a diagnosis needs symptoms or signs and low results on two total testosterone tests on separate days, both taken early in the morning. It calls under 300 ng/dL a reasonable cut-off to support the diagnosis. The Endocrine Society also stresses repeat morning, fasting tests and looking for the cause. One number on its own is not a diagnosis. No quiz is either.

Total testosterone is all the testosterone in your blood. Some programs also ask about LH (luteinizing hormone) and FSH (follicle-stimulating hormone) — signals from the brain that help show where the problem starts.

The prior authorization checklist

Ask your prescriber's office whether the request includes:

1. Your symptoms, written in your chart
2. Two early-morning testosterone results on separate days — recent ones (Florida's criteria want both within six months)
3. A diagnosis of hypogonadism — not erectile dysfunction alone
4. LH and FSH, if required — Pennsylvania lists them as examples of findings that can support the diagnosis
5. Safety labs your state checks — Nevada, for example, excludes initial topical treatment when hematocrit (share of your blood made of red cells) is over 50%
6. Proof you tried the preferred product, or a medical reason for an exception, if your plan requires it
7. Your prescriber's Medicaid enrollment (more on this next — it matters)

Already on TRT and switching to Medicaid?

Initial and renewal rules are often different. New York's list asks for an on-treatment level. When switching coverage, ask whether the new plan will honor your existing approval, offer transition coverage, or require a new request. Get your old lab results and records to your new clinician. Don't stop or change treatment on your own to "get a qualifying number" — that's a medical decision, and it can be unsafe.

Want kids soon? Say so first.

Testosterone therapy can lower spermatogenesis (sperm production). The AUA says TRT's effects on sperm production should be discussed with men interested in future fertility, and advises against testosterone while trying to conceive. If pregnancy is in your near-term plans, start with a urologist or reproductive urologist. Medicines like hCG or clomiphene are not TRT and aren't interchangeable with it. Read more in does TRT affect fertility.

---

Who can prescribe TRT on Medicaid?

For Medicaid-covered care, start with a clinician who accepts your plan — usually a primary care doctor, a community health center, a urologist, or an endocrinologist. Also confirm that the individual prescriber is enrolled with your state's Medicaid; enrollment requirements can affect whether the pharmacy claim is paid.

This is the hidden trap.

Federal regulation (42 CFR 455.410) requires Medicaid to enroll the clinicians who order and prescribe. Enforcement dates differ. Maryland Medicaid started denying pharmacy claims from unenrolled prescribers on July 1, 2024. Medi-Cal Rx's September 2026 update says it will begin enforcing prescriber enrollment in 2027. The individual prescriber must enroll; a managed-care affiliation or Medicare enrollment alone does not satisfy that requirement.

What that means for you: if the individual prescriber is not enrolled with your state's Medicaid, the pharmacy claim may be denied — even if the drug itself is covered. Enrollment for ordering or prescribing does not by itself mean the office visit is covered.

Where to start

• Primary care. A practical first call, especially if you already have a clinician. Ask whether the office handles prior authorization.
• Community health centers. These typically accept Medicaid — confirm with the center.
• Urology. Good when fertility or prostate questions are part of the picture.
• Endocrinology. A specialist route for complex cases, like suspected pituitary problems.

What to say when you call the office

"I have Medicaid through [plan name]. I'd like to be checked for low testosterone. Does this office accept my plan, and is the clinician enrolled with my state's Medicaid? Can you order two early-morning testosterone tests? If they're low, does your office handle the prior authorization?"

Telehealth

Medicaid covers many telehealth visits — check your plan. Testosterone is a Schedule III controlled substance and requires a valid prescription. Federal rules currently let authorized clinicians prescribe controlled medicines by qualifying telehealth encounters without a first in-person visit through December 31, 2026, when other federal and state rules are met. That rule doesn't create Medicaid coverage, and some clinicians still require an in-person visit.

---

How do I check my Medicaid testosterone coverage?

Call member services with the exact prescription (if you have one). Ask who handles your drug benefit, which policy applies, and whether your clinician, lab, and pharmacy can bill your plan. Write down every answer, the date, and a reference number before you agree to any charges.

Here's the free checklist. No email, no sign-up. Print it or screenshot it.

Before you call, have: your Medicaid card, the exact medicine name (if prescribed), and the names of your clinician, lab, and pharmacy.

Opening script:

"I have Medicaid through [plan]. I need to check coverage for testosterone prescribed for [the diagnosis my clinician documented]. Who handles my pharmacy benefit? Please check the exact product, whether prior authorization is needed, which clinicians and pharmacies participate, and what I might owe for the medicine, visits, tests, and supplies."

Not diagnosed yet? Swap "testosterone prescribed" for "a visit and blood tests to check for low testosterone."

Not sure which office runs your Medicaid? Use the official Medicaid.gov state contact directory.

→ Got your answers? Use these questions, then book with an enrolled clinician using the script in the section above.

---

How much does TRT cost with Medicaid?

Your costs depend on your state, eligibility category, and covered services. Federal rules limit prescription cost sharing, and some members are exempt. Visits and lab tests are Medicaid benefits too, though your plan's own charges and rules apply.

Your Medicaid money and timing rights

These protections come from federal law. Each has conditions; the drug-PA rules below apply to covered outpatient drugs, not every office procedure.

Three ways to pay for TRT — what each price includes

There is no honest national savings total without your actual Medicaid costs and a complete cash quote. For most Medicaid readers, checking the Medicaid path is the right first move.

To compare a full first year: add the initial visit and testing, any repeat diagnostic test, all membership or follow-up fees, all prescribed medicine, supplies, shipping, and monitoring. Count an included service once. For Male Excel, the advertised arithmetic is $99 + (12 × $99) + (12 × $120) = $2,727; it assumes 12 months at the injection-plan starting price. The recurring floor is $219 a month, with a 60-day medication supply billed every other month. Ask for the full written total before paying.

---

What should you do if Medicaid denies TRT?

Read the reason and appeal deadline on the notice. Ask your prescriber whether to correct missing records, request a product exception, or appeal a clinical decision. Do not let a correction or resubmission make you miss the appeal deadline.

A denial tells you why the request was not approved. It may involve paperwork, a product rule, prescriber enrollment, or clinical criteria. Ask your clinician which issue applies.

Why denials happen — and what to ask next

Which appeal path applies?

• Medicaid health plan (managed care) denial: For most plans, request an appeal within 60 calendar days from the date on the adverse-benefit notice. After the plan appeal, the state sets a 90–120-calendar-day window from the appeal-resolution notice to request a state fair hearing. Some integrated Medicare-Medicaid plans have different procedures. Appeal rule; hearing rule.
• Direct state (fee-for-service) denial: Follow the hearing steps on your notice. The state sets a reasonable deadline, no more than 90 days after the action notice is mailed; you may have less time. State-hearing rule.
• Want benefits to keep going during the appeal? If previously authorized care is being stopped or reduced, ask immediately about continued benefits. For managed care, the initial request deadline is the later of 10 calendar days after the notice is sent or the proposed action date; other conditions apply, including an unexpired authorization. A separate short deadline applies after an appeal denial. Ask whether you could owe the cost if you lose. Continuation rule.

Follow the appeal instructions and deadline on your notice; ask for help immediately if they are missing or unclear. For an appeal letter template, see our testosterone prior authorization guide.

→ Denied? Use the call script above to get the exact reason and appeal deadline in writing.

---

Do online TRT clinics take Medicaid?

The online TRT programs we checked — Male Excel and Hone Health — don't accept Medicaid or any insurance. Their published terms make them cash-pay options, so do not budget on Medicaid reimbursement. If your goal is to use Medicaid, start with a clinician who accepts your plan, whether visits are local or covered telehealth.

So when is a cash program worth considering for someone with Medicaid? Only when all three checks fit:

• Medicaid coverage is unavailable for the proposed care, or a denial remains after you and your clinician review the appeal options
• A licensed clinician still finds treatment appropriate after a full evaluation; paying cash is not a way around a safety concern
• You can comfortably afford it — without cutting into rent, food, or other bills

If none of those fit, close this tab and call member services. That's the honest answer. If only some fit, resolve the missing piece before paying.

If Medicaid isn't an option: Male Excel

Disclosure: TRT Provider Guide may earn a commission if you start care through the Male Excel link below. That never changes what we verify or who we tell to choose something else. Our method is explained in How We Review TRT Providers. Read our affiliate disclosure.

Best for: someone who can't use Medicaid for TRT, lives in a state Male Excel serves, wants at-home testing and shipped medication, and can afford the advertised recurring floor of $219 a month, plus the $99 start, shipping, and any applicable extras.

Not for you if: you qualify for Medicaid coverage; you live in Alabama, Alaska, Arkansas, Connecticut, Hawaii, Idaho, Louisiana, Minnesota, Mississippi, New Hampshire, or Rhode Island; you're trying to conceive soon; or the monthly cost would strain your budget. Also look elsewhere if you need an FDA-approved testosterone product or want to use your own pharmacy: Male Excel describes a compounded program and restricts dispensing to contracted pharmacies.

The tradeoff, straight: Male Excel does not take Medicaid — or any insurance — and its terms say no claim will be sent to Medicaid for you. If keeping your costs near zero is your priority, a Medicaid-enrolled clinician is the better fit, and the steps above get you there. But because Male Excel skips insurance entirely, there's no insurer prior authorization or preferred-drug step rule. Clinical evaluation, follow-up, and refill requirements still apply. Male Excel says the $99 start includes an at-home hormone test, a U.S.-licensed provider reviews your results, and medication ships to you with no contract.

One claim to separate from the offer: Male Excel's pricing page says insurance stops covering treatment once testosterone reaches a normal level. That is not a reliable Medicaid rule. Florida's posted renewal criteria explicitly call for a normal on-treatment level. Use your plan's policy when deciding whether coverage is still available.

What we actually verified (October 22, 2026)

These checks confirm what the provider publishes. They do not establish your eligibility, a prescription, or the quality of care you will receive.

Pharmacy record check: Male Excel's FAQ names AnazaoHealth's Tampa pharmacy. FDA's August 2025 inspection observations concern AnazaoHealth's separate Las Vegas facility, including pellet testing, sterile processes, and complaint investigations. The FDA register checked October 22, 2026 lists that inspection as open, meaning FDA has not decided whether further action will be taken. Inspection observations are not a final compliance ruling. We did not establish that this facility supplies Male Excel's TRT. Ask for the exact dispensing pharmacy, address, and product before paying.

If that tradeoff fits what you're looking for, see Male Excel's current pricing and check state availability.

---

What happens after Medicaid approves TRT?

You'll need follow-up visits and blood tests, and your approval may need renewal before a year is up. Your clinician will also watch blood pressure, red blood cell count, and prostate health as appropriate. Keep the plan's approval end date separate from your clinician's follow-up schedule.

• Renewal. Florida's criteria and Nevada's current topical policy use one-year approvals. Iowa's initial approval is three months; PA Health & Wellness's current policy uses six months initially and twelve months for renewal. New York asks for a testosterone level once you're on treatment. Put your renewal date on your calendar the day you're approved.
• Blood pressure. In February 2025, the FDA announced class-wide labeling changes to add or update blood-pressure warnings after studies showed increases across testosterone products. It also called for removing boxed-warning language about increased cardiovascular risk after the large TRAVERSE trial. That label change is not a promise of no heart or blood-pressure risk.
• Red blood cells. Testosterone can raise hematocrit. Nevada's initial topical criteria exclude treatment when hematocrit is over 50%; that is a specific coverage rule, not a self-treatment cutoff. See TRT and high hematocrit.
• Prostate. PSA (prostate-specific antigen) is a blood test your clinician may check before and during treatment.

---

What situations change your coverage or care route?

Having Medicare too, wanting children soon, being under 18, or getting testosterone for a reason other than male hypogonadism can change who pays or who you should see first. Use the policy and clinical guidance for your situation; the adult-male hypogonadism rules are not a universal test for testosterone care.

You have both Medicare and Medicaid

People with Medicare and full Medicaid generally get prescription coverage through Medicare (Part D), not Medicaid. Ask which benefit handles your testosterone. See Medicare's explanation of dual coverage.

Your plan says no to "age-related" low testosterone

Some posted criteria, like Iowa's June 2025 form, still don't authorize TRT for age-related hypogonadism under that policy. In June 2026, the FDA asked drug makers to remove the label language saying TRT's safety and effectiveness in age-related hypogonadism hadn't been established. A requested label change doesn't automatically rewrite your plan's policy. If this is your denial reason, ask your clinician whether an appeal makes sense. FDA/HHS announcement.

You're trying to have a baby

Start with fertility, not TRT. Testosterone can suppress sperm production. A urologist or reproductive urologist is usually the right first stop.

You're under 18, or testosterone is for gender-affirming care

The adult-male rules on this page don't apply. Testosterone prescribed for a child or teenager needs the clinical and coverage criteria for that condition. A federal rule effective October 13, 2026 restricts federal Medicaid funding for gender-affirming treatment under age 18 and separate CHIP funding under age 19. It includes limited exceptions and a transition of up to six months for qualifying patients already receiving hormone therapy on the effective date. It does not apply to testosterone used for other covered medical indications. State-funded coverage may differ, so ask the plan and treating clinician which rules apply. For adults receiving gender-affirming care, ask for the policy that covers that use.

You're a woman asking about testosterone

The rules and evidence are different. Ask your plan for the policy for the proposed use. Talk with your clinician about options built for your situation.

You just moved or just got Medicaid

Ask the new plan whether it will honor the existing authorization, provide transition coverage, or require a new request. Ask what it needs, and bring your old lab results.

Urgent symptoms

Call 911 for chest pain, trouble breathing, or stroke symptoms, including sudden severe headache or sudden vision changes. Seek prompt medical care for new leg swelling or pain. Don't wait for a coverage answer. CDC blood-clot guidance; CDC stroke signs.

---

How did we verify this guide?

We read official drug lists, prior authorization forms, or Medicaid health plan policies for 14 state and plan examples, plus federal rules on copays, appeals, and prescriber enrollment, and checked provider terms and pricing on October 22, 2026. Every row in our table links to its source and shows its date or scope.

What we did:

• Pulled each program's own document and recorded its date
• Lined them up on the same columns so differences jump out
• Read the full Massachusetts hearing decision to learn why that request failed
• Checked federal rules at Medicaid.gov and in the Code of Federal Regulations
• Checked Male Excel's pricing page, FAQ, homepage, terms of service, and refund conditions, and Hone Health's self-payment agreement

What we did not do: submit any claim, test any plan's approval, or sign up with any provider. Your state's rules can change. Your plan applies its coverage rules, and you can challenge a denial through the applicable appeal process.

This guide follows our method, How We Review TRT Providers, which separates verified facts, provider-stated facts, customer experiences, and our own conclusions. This page does not use customer testimonials or ratings. Policies change; the date at the top records this document review. See our About page, editorial standards, and corrections policy. Before sharing personal information through the site, read our privacy policy.

---

Frequently asked questions

Coverage depends on the exact product, benefit, and plan rules. A listed medicine or one low result does not by itself guarantee approval.

Does Medicaid cover testosterone injections?

Yes, the examples above include covered or preferred injections, subject to the program's rules. Cypionate and enanthate appear on several lists, but an injection-first rule is not universal. Prior authorization can still be required.

Does Medicaid cover testosterone gel or AndroGel?

Sometimes. Some states prefer certain gels; non-preferred gels may require trials of preferred products or an approved medical exception. New York prefers the generic gel pump, while North Carolina prefers both the brand and generic pump.

Does Medicaid pay for TRT blood work?

Lab services are a Medicaid benefit. Use a lab your plan works with and tests ordered by an enrolled clinician. Ask whether the initial test, repeat morning test, and follow-up tests are covered. The at-home kits in the two cash programs reviewed here are not billed to Medicaid by those programs.

How long does Medicaid prior authorization for testosterone take?

For covered outpatient drugs, federal law requires a response within 24 hours of a PA request; that is not a promise of approval. Ask whether the request was received, whether records are missing, and what response was issued.

How long does an approval last?

It depends on the program and whether this is an initial approval or renewal. Florida's criteria and Nevada's topical policy use one year; Iowa's initial approval is three months, and PA Health & Wellness's is six months. Ask for your actual end date and renewal records.

Will Medicaid cover TRT if my testosterone is just under 300?

One result isn't enough to diagnose testosterone deficiency. Clinical guidance requires symptoms or signs and consistently low results with repeat morning testing. Coverage criteria differ: some use 300 ng/dL, others use the lab's range or additional clinical evidence.

Do any TRT clinics accept Medicaid?

Some local clinicians and community health centers accept Medicaid; confirm your exact plan and whether the office evaluates low testosterone. The two online cash programs we checked do not accept insurance. Covered telehealth through a participating clinician is a separate option to ask your plan about.

Can I use Medicaid for a prescription from an online TRT clinic?

It depends on the prescriber's Medicaid enrollment, your plan's rules, the product, and the dispensing pharmacy. Enrollment requirements can affect payment even when the drug is covered. Some online programs also only send prescriptions to their own pharmacies.

Does Medicaid cover compounded testosterone?

Coverage depends on your program and the medical-necessity evidence. Compounded drugs aren't FDA-approved. Ask about the exact compounded product and whether a covered FDA-approved option can meet your needs.

Does Medicaid cover testosterone pellets?

Sometimes, with prior authorization. Pennsylvania lists Testopel as preferred with PA; Florida's posted criteria list it as non-preferred. Because pellets are placed in a clinician's office, check both the product and procedure benefit.

I have Medicare and Medicaid. Who pays for testosterone?

People with Medicare and full-benefit Medicaid generally get prescription coverage through Medicare and automatically qualify for Extra Help with Medicare drug costs. Ask which benefit handles your exact testosterone product, especially if it is given in an office.

Can I appeal a Medicaid testosterone denial?

Yes. For most Medicaid managed-care plans, request a plan appeal within 60 calendar days from the notice date, then a state fair hearing if needed. Direct state coverage has a different hearing deadline. Check the dates on your notice right away.

---

What should you do next?

Medicaid can cover TRT when your request meets the applicable rules. The next steps are clear:

1. See an enrolled clinician — primary care, a health center, urology, or endocrinology
2. Get a real evaluation, including repeat early-morning testing as your clinician directs
3. Let the office send prior authorization if required, with the records and product-exception evidence your plan needs
4. If you're denied, get the reason and deadline in writing, address the issue with your clinician, and appeal on time

Still not sure whether an online TRT program fits you? Use our free Find My TRT Path tool. It's educational, it doesn't diagnose, and it doesn't replace your clinician — it helps you explore online programs and the questions to ask before you pay. For Medicaid benefits, use the coverage checklist.

For a broader look at providers and billing, see TRT providers that take insurance.

---

Sources

Sources checked October 22, 2026. Document dates are shown above so older posted policies are not mistaken for new rules.

Federal law and agencies

• Medicaid.gov — Prescription Drugs
• Medicaid.gov — Mandatory & Optional Benefits
• Medicaid.gov — Cost Sharing
• Social Security Act §1927 (drug coverage, exclusions, prior authorization timing)
• 42 CFR 447.56 (cost-sharing exemptions)
• 42 CFR 447.53 (drug copay limits)
• 42 CFR 438.402, 438.408, 438.420, 431.221 (appeals and fair hearings)
• 42 CFR 455.410 (prescriber enrollment)
• 42 CFR Part 12 (telemedicine prescribing flexibility through Dec. 31, 2026)
• 21 CFR 1308.13 (testosterone, Schedule III)
• Medicare.gov — Medicaid and dual coverage
• Medicaid.gov — State contact directory
• FDA — Class-wide labeling changes for testosterone products (Feb. 28, 2025)
• HHS — Requested updates to testosterone labels (June 18, 2026)
• FDA — Compounding questions and answers
• Federal Register — Final rule on federal Medicaid/CHIP funding for specified treatment of minors (Aug. 13, 2026; effective Oct. 13, 2026)
• FDA — Androderm marketing status, Drugs@FDA
• CDC — About Venous Thromboembolism; Signs and Symptoms of Stroke
• FDA — AnazaoHealth Las Vegas inspection observations, August 8, 2025; registered outsourcing facilities and inspection-status definitions

Clinical guidelines

• American Urological Association — AUA-issued summary of its testosterone-deficiency guideline (April 10, 2018); guideline page
• Endocrine Society — Testosterone Therapy in Men with Hypogonadism

Prescriber enrollment

• Medi-Cal Rx — Requirement for prescriber enrollment (2026)
• Maryland Medicaid — Prescriber enrollment reference guide (June 21, 2024)

State Medicaid programs and plans

• California — Medi-Cal Rx Contract Drugs List; DHCS policy letter on compounded drugs
• New York — NYRx Preferred Drug List
• North Carolina — NC Medicaid PDL, October 2026
• Florida — AHCA testosterone criteria; Sunshine Health criteria
• Texas — TMHP Outpatient Drug Services Handbook, October 2026, §6.62.9; Superior hormonal therapy policy, reviewed March 31, 2026; March 2024 implementation notice
• Illinois — Meridian pharmacy guidance; 2026 preferred-drug change notices
• Iowa — PDL effective October 1, 2026; testosterone PA form, revised June 2025; pharmacy administration transition notice, effective December 1, 2026
• Nevada — Medicaid Services Manual, October 5, 2026, Appendix A topical androgens
• Ohio — Unified PDL effective October 1, 2026
• Pennsylvania — Statewide PDL, January 2026 v16; state androgen criteria, effective January 8, 2024; PA Health & Wellness androgen policy, 2026
• Oregon — Oregon PDL, androgens; linked testosterone PA criteria
• Arizona — AHCCCS Acute–Long Term Care Drug List, October 2026
• Oklahoma — OHCA 2026 endocrine criteria
• Washington — UHC Apple Health PDL

Public hearing decision

• Massachusetts — MassHealth appeal decision

Providers and prices

• Male Excel — Pricing, FAQ, current program and membership description, Terms & Conditions, limited membership-refund conditions
• Hone Health — Agreement for Self-Payment of Services, updated September 3, 2026
• SingleCare — Testosterone cypionate cash-price example, June 15, 2026